Federal Reserve Bank of New York

An inspector calls

Since his appointment last December, Tarp inspector Neil Barofsky has conducted a range of audits and investigations into sensitive issues – most recently condemning the US Treasury’s oversight of AIG’s compensation policies. He speaks to Mark Pengelly…

Basel liquidity standards due in December

The Basel Committee on Banking Supervision is set to unveil quantitative liquidity requirements for public consultation at its quarterly meeting in December, the co-chair of the committee's liquidity working group has told Risk News.

CMBS re-Remics could make Talf obsolete

A wave of downgrades to highly rated commercial mortgage-backed securities (CMBS) is threatening plans by the US Federal Reserve to rehabilitate the market for existing deals. But a recent trend towards restructuring the transactions could render the…

Trade set and match

The ultimate objective of regulators and participants in the derivatives business is to see submission and matching on the date of trade. How far is the industry from reaching this goal? By Ryan Davidson

Damage limitation

Efforts are under way to formalise the resolution process for collateral disputes, while other initiatives are planned to improve processes for posting collateral, valuation and margin practices. What are the challenges to meeting these targets? Ryan…

AIG warns of potential losses in CDS portfolio

AIG could be exposed to further losses on the super-senior credit default swap (CDS) portfolio held by its subsidiary AIG Financial Products (AIG FP) should credit markets continue to deteriorate, according to a filing the company made to the US…

OTC trade repository plan faces hurdles

Financial authorities in the US and Europe have advocated the introduction of a central trade repository to gather data on the over-the-counter (OTC) derivatives market, but there is concern that multiple repositories could do more harm than good.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here